This inventor holds 2 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents. Top assignee: Gilead Sciences, Inc.. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2021
Title: Brenda J Burke Chan: Innovator in Pharmaceutical Sciences
Introduction
Brenda J Burke Chan, based in Foster City, CA, is a passionate inventor with a notable contribution to the field of pharmaceutical sciences. With a focus on developing innovative compounds, she holds two patents that showcase her expertise and dedication to advancing medical treatments.
Latest Patents
Among her most recent patents is the development of solid forms of an ASK1 inhibitor. This includes crystalline forms of the compound known as 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compound I). These crystalline forms have been meticulously prepared and characterized in the solid state. Additionally, the patent outlines processes of manufacture and methods of utilizing these crystalline forms, further emphasizing the practical applications of her work.
Career Highlights
Brenda is currently associated with Gilead Sciences, Inc., where she plays an instrumental role in research and development. Her contributions to the company are significant as she works on projects that aim to bring new therapeutic options to the market. With a background in chemistry and a strong commitment to innovation, Brenda continues to make strides in her field.
Collaborations
Throughout her career, Brenda has collaborated with talented individuals including Mark Andres and Ernest A Carra. These partnerships have enhanced her research initiatives and have allowed for a sharing of ideas that drive innovation in pharmaceutical sciences.
Conclusion
Brenda J Burke Chan exemplifies the spirit of innovation within the pharmaceutical industry. Her patents not only reflect her expertise as an inventor but also her commitment to creating solutions that can impact patient care. As she continues to work at Gilead Sciences, she is sure to contribute even more groundbreaking advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
